NasdaqCM - Delayed Quote USD
Journey Medical Corporation (DERM)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-7,968.00
5,240.00
-13,534.00
-2,181.00
5,132.00
--
Investing Cash Flow
--
-5,000.00
-20,000.00
-10,000.00
-1,200.00
--
Financing Cash Flow
14,900.00
-4,804.00
16,456.00
53,016.00
-487.00
--
End Cash Position
23,912.00
27,439.00
32,003.00
49,081.00
8,246.00
--
Income Tax Paid Supplemental Data
199.00
181.00
168.00
158.00
110.00
--
Interest Paid Supplemental Data
872.00
1,127.00
993.00
--
--
--
Capital Expenditure
--
-5,000.00
-20,000.00
-10,000.00
-1,200.00
--
Issuance of Capital Stock
5,978.00
4,494.00
--
51,503.00
--
--
Issuance of Debt
20,000.00
43,000.00
24,763.00
16,540.00
--
--
Repayment of Debt
-11,000.00
-51,948.00
-7,864.00
-11,488.00
-500.00
--
Free Cash Flow
-7,968.00
240.00
-33,534.00
-12,181.00
3,932.00
--
12/31/2019 - 11/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPTN OptiNose, Inc.
0.7800
-2.50%
BFRI Biofrontera Inc.
0.9427
+12.23%
AVDL Avadel Pharmaceuticals plc
13.42
-1.07%
ETON Eton Pharmaceuticals, Inc.
8.44
+1.08%
ALKS Alkermes plc
27.71
-1.98%
SUPN Supernus Pharmaceuticals, Inc.
33.67
-2.52%
ELTP Elite Pharmaceuticals, Inc.
0.7100
+0.71%
ESPR Esperion Therapeutics, Inc.
2.0600
+0.98%
AQST Aquestive Therapeutics, Inc.
4.9500
-1.59%
ITCI Intra-Cellular Therapies, Inc.
76.91
-1.83%